{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:55:53Z","timestamp":1781632553549,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Severe fever with thrombocytopenia syndrome (SFTS), caused by the novel Bunyavirus (NBV), is a tick-borne infectious disease associated with high morbidity and mortality. Currently, no effective treatment or vaccine exists for SFTS. Early identification of prognostic factors is crucial for clinical management. This study aimed to evaluate the prognostic value of the procalcitonin\/albumin to urea nitrogen ratio (PAU) in SFTS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective observational study enrolled 259 consecutive patients with SFTS admitted to Tongji Hospital from April 2023 to November 2024. Patients were stratified into survival (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009172) and death (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200987) groups based on clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multivariable logistic regression identified advanced age, altered mental status (AMS), elevated PAU and high viral load as independent predictors of adverse outcome in SFTS. PAU exhibited strong discriminative performance (AUC 0.810; 95% CI 0.757\u20130.857; sensitivity 75.7%, specificity 73.0%), with an optimal cut-off of 0.06 \u00b5mol\/L. Integration of PAU with age, viral load and AMS further improved accuracy (AUC 0.897; 95% CI 0.858\u20130.936). Bootstrap internal validation yielded a calibration curve closely approximating the diagonal, confirming robust predictive efficacy of the composite model.Kaplan-Meier analysis revealed significantly worse prognosis in high-PAU patients (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).The longitudinal trend analysis revealed an increasing trend in PAU among non-survivors, while survivors exhibited a decreasing trend.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PAU represents a novel composite biomarker that integrates inflammatory and organ dysfunction parameters, providing reliable prognostic prediction for SFTS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12736-6","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:16:52Z","timestamp":1769710612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Procalcitonin\/albumin to urea nitrogen ratio: a novel prognostic indicator for severe fever with thrombocytopenia syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Song","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"16","key":"12736_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","volume":"364","author":"XJ Yu","year":"2011","unstructured":"Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523\u201332.","journal-title":"N Engl J Med"},{"key":"12736_CR2","doi-asserted-by":"crossref","unstructured":"Seo JW, Kim D, Yun N et al. Clinical update of severe fever with thrombocytopenia syndrome. Viruses. 2021;13(7).","DOI":"10.3390\/v13071213"},{"issue":"9","key":"12736_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","volume":"29","author":"H Li","year":"2019","unstructured":"Li H, Zhang LK, Li SF, et al. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res. 2019;29(9):739\u201353.","journal-title":"Cell Res"},{"issue":"3","key":"12736_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3892\/ijmm.2022.5174","volume":"50","author":"T Yang","year":"2022","unstructured":"Yang T, Huang HY, Jiang LF, et al. Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review). Int J Mol Med. 2022;50(3):12.","journal-title":"Int J Mol Med"},{"key":"12736_CR5","doi-asserted-by":"publisher","first-page":"907888","DOI":"10.3389\/fmicb.2022.907888","volume":"13","author":"Y Wei","year":"2022","unstructured":"Wei Y, Wang Z, Kang L, et al. A convenient Early-Warning biomarker of fatal outcome in patients with severe fever with thrombocytopenia syndrome. Front Microbiol. 2022;13:907888.","journal-title":"Front Microbiol"},{"issue":"3","key":"12736_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21037\/atm-20-4736","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Lin L, Zhao Z, et al. The predictive effect of the platelet-to-lymphocyte ratio (PLR) and the neutrophil-to-lymphocyte ratio (NLR) on the risk of death in patients with severe fever with thrombocytopenia syndrome (SFTS): a multi-center study in China. Ann Transl Med. 2021;9(3):208.","journal-title":"Ann Transl Med"},{"key":"12736_CR7","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.2147\/JIR.S335727","volume":"14","author":"Y Gui","year":"2021","unstructured":"Gui Y, Xu Y, Yang P. Predictive value of the Platelet-to-Albumin ratio (PAR) on the risk of death at admission in patients suffering from severe fever with thrombocytopenia syndrome. J Inflamm Res. 2021;14:5647\u201352.","journal-title":"J Inflamm Res"},{"key":"12736_CR8","doi-asserted-by":"publisher","first-page":"725642","DOI":"10.3389\/fcimb.2022.725642","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Xu Y, Zhang S, et al. The AST\/ALT ratio (De Ritis ratio) represents an unfavorable prognosis in patients in Early-Stage SFTS: an observational cohort study. Front Cell Infect Microbiol. 2022;12:725642.","journal-title":"Front Cell Infect Microbiol"},{"key":"12736_CR9","doi-asserted-by":"publisher","first-page":"112288","DOI":"10.1016\/j.intimp.2024.112288","volume":"136","author":"Z Liu","year":"2024","unstructured":"Liu Z, Ge Z, Pan W, et al. Development and validation of the PLNA score to predict cytokine storm in acute-phase SFTS patients: A single-center cohort study. Int Immunopharmacol. 2024;136:112288.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"12736_CR10","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/infdis\/jiad426","volume":"229","author":"H Hou","year":"2024","unstructured":"Hou H, Zou S, Wei W, et al. Kinetics and prognostic significance of laboratory markers in patients with severe fever with thrombocytopenia syndrome: insight from a comprehensive analysis. J Infect Dis. 2024;229(6):1845\u201355.","journal-title":"J Infect Dis"},{"key":"12736_CR11","doi-asserted-by":"publisher","first-page":"109262","DOI":"10.1016\/j.clim.2023.109262","volume":"248","author":"M Huang","year":"2023","unstructured":"Huang M, Wang T, Huang Y, et al. The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection. Clin Immunol. 2023;248:109262.","journal-title":"Clin Immunol"},{"issue":"1","key":"12736_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4269\/ajtmh.23-0811","volume":"111","author":"K Cao","year":"2024","unstructured":"Cao K, Ma A, Zhang K, et al. Blood Urea Nitrogen-to-Serum albumin ratio predicts fatal outcomes in severe fever with thrombocytopenia syndrome patients. Am J Trop Med Hyg. 2024;111(1):113\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"12736_CR13","doi-asserted-by":"publisher","first-page":"e0013207","DOI":"10.1371\/journal.pntd.0013207","volume":"19","author":"B Zhang","year":"2025","unstructured":"Zhang B, Gong JL, Zeng HL, et al. Unveiling fatal risk factors: predicting hemophagocytic lymphohistiocytosis in SFTS patients. PLoS Negl Trop Dis. 2025;19(6):e0013207.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"12736_CR14","first-page":"450","volume":"39","author":"TD Cakirca","year":"2023","unstructured":"Cakirca TD, Cakirca G, Torun A, et al. Comparing the predictive values of procalcitonin\/albumin ratio and other inflammatory markers in determining COVID-19 severity. Pak J Med Sci. 2023;39(2):450\u20135.","journal-title":"Pak J Med Sci"},{"issue":"12","key":"12736_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/0885066616685300","volume":"33","author":"M Yin","year":"2018","unstructured":"Yin M, Si L, Qin W, et al. Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration: A prospective cohort study. J Intensive Care Med. 2018;33(12):687\u201394.","journal-title":"J Intensive Care Med"},{"issue":"1\u20132","key":"12736_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/CH-189111","volume":"69","author":"B Wernly","year":"2018","unstructured":"Wernly B, Lichtenauer M, Vellinga NAR, et al. Blood Urea nitrogen (BUN) independently predicts mortality in critically ill patients admitted to ICU: A multicenter study. Clin Hemorheol Microcirc. 2018;69(1\u20132):123\u201331.","journal-title":"Clin Hemorheol Microcirc"},{"key":"12736_CR17","doi-asserted-by":"publisher","first-page":"1168381","DOI":"10.3389\/fmicb.2023.1168381","volume":"14","author":"K Chen","year":"2023","unstructured":"Chen K, Sun H, Geng Y, et al. Ferritin and procalcitonin serve as discriminative inflammatory biomarkers and can predict the prognosis of severe fever with thrombocytopenia syndrome in its early stages. Front Microbiol. 2023;14:1168381.","journal-title":"Front Microbiol"},{"key":"12736_CR18","doi-asserted-by":"crossref","unstructured":"Yan S, Ding X, Gao Q et al. Prediction of mortality by clinical laboratory parameters in severe fever with thrombocytopenia syndrome: a meta-analysis. Trop Med Infect Dis. 2025;10(7).","DOI":"10.3390\/tropicalmed10070193"},{"key":"12736_CR19","doi-asserted-by":"publisher","first-page":"1459712","DOI":"10.3389\/fpubh.2024.1459712","volume":"12","author":"T Meng","year":"2024","unstructured":"Meng T, Ding W, Lv D, et al. Lactate dehydrogenase to albumin ratio (LAR) is a novel predictor of fatal outcome in patients with SFTS: an observational study. Front Public Health. 2024;12:1459712.","journal-title":"Front Public Health"},{"key":"12736_CR20","doi-asserted-by":"publisher","first-page":"732410","DOI":"10.3389\/fmed.2021.732410","volume":"8","author":"X Chen","year":"2021","unstructured":"Chen X, Zhou X, Zhao H, et al. Clinical value of the Lactate\/Albumin ratio and Lactate\/Albumin ratio x age score in the assessment of prognosis in patients with sepsis. Front Med (Lausanne). 2021;8:732410.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"12736_CR21","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1002\/jmv.27972","volume":"94","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhang R, Zhou W, et al. High levels of C-reactive protein-to-albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage. J Med Virol. 2022;94(11):5375\u201384.","journal-title":"J Med Virol"},{"issue":"1","key":"12736_CR22","doi-asserted-by":"publisher","first-page":"9293","DOI":"10.1038\/s41598-025-94416-0","volume":"15","author":"HJ Woo","year":"2025","unstructured":"Woo HJ, Heo ST, Yoo JR, et al. Dynamic biomarkers and Cox regression with time-dependent covariate for mortality prediction in severe fever with thrombocytopenia syndrome. Sci Rep. 2025;15(1):9293.","journal-title":"Sci Rep"},{"issue":"11","key":"12736_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","volume":"17","author":"M Legrand","year":"2021","unstructured":"Legrand M, Bell S, Forni L, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751\u201364.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"12736_CR24","doi-asserted-by":"publisher","first-page":"e2176","DOI":"10.1002\/rmv.2176","volume":"31","author":"E Ahmadian","year":"2021","unstructured":"Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, et al. Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3):e2176.","journal-title":"Rev Med Virol"},{"key":"12736_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ajem.2021.03.090","volume":"48","author":"K K\u00fc\u00e7\u00fckceran","year":"2021","unstructured":"K\u00fc\u00e7\u00fckceran K, Ayranc\u0131 MK, Giri\u015fgin AS, et al. The role of the BUN\/albumin ratio in predicting mortality in COVID-19 patients in the emergency department. Am J Emerg Med. 2021;48:33\u20137.","journal-title":"Am J Emerg Med"},{"issue":"7","key":"12736_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/infdis\/jis452","volume":"206","author":"Y Sun","year":"2012","unstructured":"Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis. 2012;206(7):1085\u201394.","journal-title":"J Infect Dis"},{"issue":"5","key":"12736_CR27","doi-asserted-by":"publisher","first-page":"e1009587","DOI":"10.1371\/journal.ppat.1009587","volume":"17","author":"S Xu","year":"2021","unstructured":"Xu S, Jiang N, Nawaz W, et al. Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome. PLoS Pathog. 2021;17(5):e1009587.","journal-title":"PLoS Pathog"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12736-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:21:37Z","timestamp":1781630497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12736-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12736"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12736-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (approval number: TJ-IRB202411077). The requirement for informed consent was waived by the ethics committee due to the retrospective and anonymized nature of the analysis. All patient data were de-identified before analysis to ensure privacy and confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors hereby confirm that the study is based on anonymized data and does not require consent. The manuscript does not contain any individual person\u2019s data in any form that can be used to identify the person, and all necessary steps have been taken to ensure the privacy and confidentiality of the participants\u2019 information.The institutional review board waived the requirement for informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"431"}}